Back

Aspirin dosing for secondary prevention - The ADAPTABLE trial.

31 August 2020 (12:00 - 12:13)
Organised by:
Congress Presentation Part of: Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence Trial Design ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Adrian Hernandez

Duke Clinical Research Institute, Durham (United States of America)

2 More presentations in this session

Presentation thumbnail
ABC AF Study: risk score-guided versus standard care in atrial fibrillation.
Professor J. Oldgren (Uppsala, SE)
Video
Presentation thumbnail
SPIRRIT-HFpEF: spironolactone versus usual care in HFpEF.
Professor L. Lund (Stockholm, SE)
Video

Access the full session

Session thumbnail
Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence

The Event

Event poster

ESC Congress 2020

31 August 2020 12:00 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Variability of the antithrombotic effect of acetylsalicylic acid with the administration of different dosages: reality or myth?
25 August 2023
thumbnail
Congress Presentation
Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens
1 September 2025
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources